Marshall Wace’s InflaRx IFRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.59M Buy
711,296
+156,932
+28% +$295K ﹤0.01% 1974
2026
Q1
$493K Buy
554,364
+274,324
+98% +$259K ﹤0.01% 2464
2025
Q4
$283K Sell
280,040
-27,042
-9% -$33.6K ﹤0.01% 2472
2025
Q3
$411K Buy
+307,082
New +$326K ﹤0.01% 2300
2024
Q3
Sell
-33,824
Closed -$58.9K 2709
2024
Q2
$58.9K Sell
33,824
-47,995
-59% -$70.4K ﹤0.01% 2435
2024
Q1
$126K Buy
81,819
+45,818
+127% +$74.9K ﹤0.01% 2284
2023
Q4
$58.7K Buy
36,001
+23,500
+188% +$40.3K ﹤0.01% 2070
2023
Q3
$37.3K Buy
+12,501
New +$47.6K ﹤0.01% 2100
2022
Q2
Sell
-34,353
Closed -$63K 3628
2022
Q1
$63K Buy
+34,353
New +$107K ﹤0.01% 3232

Other funds holding IFRX

Marshall Wace's IFRX Position: Q2 2026 in Review

Marshall Wace increased its InflaRx (IFRX) stake by 28% in Q2 2026, buying an estimated $295K and bringing the position to 711,296 shares worth $1.59M. The position accounts for ﹤0.01% of the portfolio, ranked #1974.

Marshall Wace first reported a position in IFRX in Q1 2022 and has held it in 9 quarters since. 62 funds tracked by Wall St. Rank hold IFRX as of Q2 2026.

  • Marshall Wace held 711,296 shares of InflaRx worth $1.59M as of Q2 2026.
  • Marshall Wace bought 156,932 InflaRx shares in Q2 2026, an estimated $295K.
  • InflaRx made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #1974 holding.
  • Marshall Wace first reported a position in InflaRx in Q1 2022 and has held it in 9 quarters since.
  • 62 funds tracked by Wall St. Rank held InflaRx as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.